MRI-guided laser ablation coagulates and necrotizes unwanted tissue in the brain. The Visualase™ MRI-guided laser ablation system consists of a small laser catheter that delivers light energy to the target area. As that light is delivered, the temperature in the target area begins to rise and is observed under real-time MRI imaging — allowing the surgeon precise control of the ablation. After the procedure, the small incision can usually be closed with a single suture,1,2 and in many cases the patient can return home the next day.3–8

A female patient is smiling.

Epileptic foci ablation

Your medically-refractory focal epilepsy patients may benefit from Visualase™ MRI-guided laser ablation. FDA-cleared to ablate epileptic foci, this minimally invasive surgical option may ultimately help patients manage their seizures when medication alone may not work.

A female patient smiling in a blue headwrap.

Brain tumor ablation

Your primary and metastatic brain tumor patients may benefit from Visualase™ MRI-guided laser ablation. FDA-cleared to ablate tumors in the brain, this minimally invasive surgical option may ultimately help patients to a speedier recovery for the continuation of their treatment.

Learn more about Visualase™ MRI‑guided laser ablation

Visualase™ MRI-guided laser ablation has been used by neurosurgeons since 2007 for precise and controlled necrotization and coagulation of soft tissue in the brain. Learn more about Visualase™ technology, equipment, and workflow.

The Visualase™ system is a minimally-invasive solution for the ablation of soft tissue, brain tumors, and epileptic foci in neurosurgery.

Reimbursement guide

Find reimbursement and coding information for Visualase™ MRI-guided laser ablation.

Medical education opportunities

Access on-demand procedural videos, webinars, and more at Medtronic Academy.

A group of physicians look toward the front of a classroom.
  1. Jethwa PR, Lee JH, Assina R, Keller IA, Danish SF. Treatment of a supratentorial primitive neuroectodermal tumor using magnetic resonance-guided laser-induced thermal therapy. J Neurosurg Pediatr. 2011;8(5):468–475. doi:10.3171/2011.8.PEDS11148.
  2. Torres-Reveron J, Tomasiewicz HC, Shetty A, Amankulor NM, Chiang VL. Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery. J Neurooncol. 2013;113(3):495–503. doi:10.1007/s11060-013-1142-2.
  3. Jethwa PR, Barrese JC, Gowda A, Shetty A, Danish SF. Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Neurosurgery. 2012;71(1 suppl operative):133–145. doi:10.1227/NEU.0b013e31826101d4.
  4. Kang JY, Wu C, Tracy J, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2):325–334. doi:10.1111/ epi.13284.
  5. Lewis EC, Weil AG, Duchowny M, Bhatia S, Ragheb J, Miller I. MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy. Epilepsia. 2015;56(10):1590–1598. doi:10.1111/epi.13106.
  6. Patel P, Patel NV, Danish SF. Intracranial MR-guided laser-induced thermal therapy: single-center experience with the Visualase thermal therapy system. J Neurosurg. 2016;125(4):853–860. doi:10.3171/2015.7.JNS15244.
  7. Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia. 2013;54(suppl 9):109–114. doi:10.1111/epi.12454.
  8. Willie JT, Laxpati NG, Drane DL, et al. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014;74(6):569–585. doi:10.1227/NEU.0000000000000343.